Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.
about
PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axisReduced expression of SIRT2 in serous ovarian carcinoma promotes cell proliferation through disinhibition of CDK4 expression.Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer.Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis.Genome-wide Analyses on Single Disease Samples for Potential Biomarkers and Biological Features of Molecular Subtypes: A Case Study in Gastric Cancer.
P2860
Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Trastuzumab Inhibits Growth of ...... n-Initialized CCKBR Signaling.
@en
type
label
Trastuzumab Inhibits Growth of ...... n-Initialized CCKBR Signaling.
@en
prefLabel
Trastuzumab Inhibits Growth of ...... n-Initialized CCKBR Signaling.
@en
P2093
P2860
P1476
Trastuzumab Inhibits Growth of ...... n-Initialized CCKBR Signaling.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10620-015-3793-7
P577
2015-07-15T00:00:00Z
P6179
1003427337